Olon

Rodano (Milan), Italy
ADC (end-to-end) HPAPI API (small molecule) Biologics (mammalian & microbial) mAb Bioconjugation Fill & Finish
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (14) ○ EMA GMP ○ MHRA GMP

Quick Facts: Olon

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Rodano (Milan), Italy
Modalities
ADC (end-to-end), HPAPI, API (small molecule), Biologics (mammalian & microbial), mAb, Bioconjugation, Fill & Finish
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Olon

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesADC (end-to-end), HPAPI, API (small molecule), Biologics (mammalian & microbial), mAb, Bioconjugation, Fill & Finish
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press14 articles
Broad modality coverage (7 modalities)

Recent News 14 articles

news Wed, 24 Ju
Olon S.p.A. Expands Microbial GMP Capabilities at Its Manufacturing Site in Capua - PR Newswire
Source →
news Wed, 05 Se
Italian CDMO buys India API plant that supplies Novartis - Fierce Pharma
Source →
news Thu, 18 Ap
Olon Buys Indian API Plant - CHEManager
Source →
news Mon, 28 Ja
Olon SpA Acquires Italian CDMO - Contract Pharma
Source →
news Fri, 25 Ja
Olon acquires fellow Italian CDMO - The Pharma Letter
Source →
news Wed, 20 Ma
Olon announces the appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division - Manufacturing Chemist
Source →
news Wed, 03 Ju
Olon Group Acquires GTP Bioways - Contract Pharma
Source →
news Tue, 29 Ap
Olon Group Announces Two Leadership Appointments - Contract Pharma
Source →
news Thu, 14 Ma
Antheia and Olon continue biomanufacturing partnership - Manufacturing Chemist
Source →
news Thu, 04 Ju
Olon Group acquires GTP Bioways to expand biotech offering - Manufacturing Chemist
Source →
news Sat, 09 No
OLON GROUP ANNOUNCES THE ACQUISITION OF GTP BIOWAYS GROUP - DCAT Value Chain Insights
Source →
news Mon, 28 Ap
Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France - Koreabizwire
Source →
news Mon, 16 Se
Olon acquires HuvePharma - Speciality Chemicals Magazine
Source →
news Mon, 04 No
Olon commits to ultra-potent compound manufacturing expansion with new €25m facility - Manufacturing Chemist
Source →

Frequently Asked Questions About Olon

What is Olon's CDMO Signal Score?
Olon has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Olon for a manufacturing program?
Use the free AI matchmaker to compare Olon against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
ADC (end-to-end) CDMOs → HPAPI CDMOs → Biologics (mammalian & microbial) CDMOs → Bioconjugation CDMOs →

Similar CDMOs

Abzena
San Diego, CA; Bristol, PA; Cambridge, UK
Signal Score: 64.0
ADC, AOC, RDC, PDC, DAC, Fusion Proteins, Bispecifics, bsAbs, Multispecifics, msAbs, Bioconjugates, Biologics, mAb, Monoclonal Antibody, Antibodies, Cytokines, HPAPI, Bioconjugation
Cerbios-Pharma
Lugano, Switzerland
ADC, HPAPI, Bioconjugation, Biologics, Oligonucleotides
Pharmaron Biologics
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
Altruist Biologics
Suzhou, China
Biologics, mAb, Bispecific/Multispecific Antibodies, Fusion Proteins, Recombinant Proteins, ADC, Cell Therapy, Gene Therapy